Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.89    0.00 (0.00%)
Bid:
1.805
Ask:
2.09
Spread: 0.285 (15.789%)
Market Cap: £37.92m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Valkor Update

24 Aug 2023 12:29

RNS Number : 3724K
Quadrise PLC
24 August 2023
 

24 August 2023

Quadrise Plc ("Quadrise" or the "Company")

Valkor Update

Quadrise Plc (AIM:QED), the supplier of innovative energy solutions for a cleaner planet, provides an update on its project with Valkor Technologies LLC ('Valkor') in Utah, USA.

A meeting of the State of Utah's Board of Oil, Gas and Mining ('the Board') was held yesterday to review a unitisation plan involving drilling of up to 119 wells to establish the Asphalt Ridge Enhanced Recovery Unit for the in-situ production of heavy oil from sands by Valkor, on behalf of project sponsors Heavy Sweet Oil LLC and AC Oil LLC.

The Board denied the order on the basis that without a producing well in place, there was not yet sufficient evidence of an oil deposit to support the unitisation plan at this time. The decision does not prevent Valkor from drilling the 4 pilot wells already granted by the Board in December 2022. Pilot well drilling will be necessary to support a further application for unitisation in due course.

Quadrise is now working with Valkor to assess and clarify any impact on the conditional site license and supply agreement for Quadrise's emulsion fuel technology announced on 12 June 2023 and a further announcement will be made as soon as practicable.

For additional information, please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cenkos Securities plc

+44 (0)20 7397 8900

Ben Jeynes

Katy Birkin

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Rachel Goldstein (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

 

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate broking)

+44 (0)20 3005 5000

Public & Investor Relations

 

 

Vigo Consulting

Patrick D'Ancona

Finlay Thomson

+44 (0)20 7390 0230

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.

Learn more at: www.quadrise.com

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFZLFLXVLLBBQ
Date   Source Headline
9th Jun 20144:30 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:30 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:30 pmRNSTotal Voting Rights
2nd Jun 20144:31 pmRNSBlocklisting Interim Review
2nd Jun 20144:30 pmRNSHolding(s) in Company
28th May 20144:30 pmRNSHolding(s) in Company
28th May 20144:29 pmRNSAdditional Listing
27th May 20144:30 pmRNSDirector/PDMR Shareholding
23rd May 20147:00 amRNSFinal Results for the year ended 31 March 2014
16th May 20147:00 amRNSDisposal of share in iQ JV to Wellcome Trust
8th May 20149:01 amRNSNotice of Results
7th May 20144:30 pmRNSDirector/PDMR Shareholding
2nd May 20144:01 pmRNSTotal Voting Rights
2nd May 20144:00 pmRNSDirector/PDMR Shareholding
1st May 20147:00 amRNSQuintain acquires Aldermary House, EC4
14th Apr 20147:00 amRNSRe Joint Venture at Wembley Park
11th Apr 20144:38 pmRNSHolding(s) in Company
9th Apr 20144:31 pmRNSReplacement Director/PDMR Shareholding
2nd Apr 20144:31 pmRNSTotal Voting Rights
2nd Apr 20144:30 pmRNSDirector/PDMR Shareholding
26th Mar 20144:30 pmRNSHolding(s) in Company
26th Mar 20143:00 pmRNSDirector Declaration
11th Mar 20149:03 amRNSDirector/PDMR Shareholding
4th Mar 20144:31 pmRNSTotal Voting Rights
4th Mar 20144:30 pmRNSDirector/PDMR Shareholding
14th Feb 20145:17 pmRNSHolding(s) in Company
12th Feb 20144:30 pmRNSHolding(s) in Company
12th Feb 20147:00 amRNSDisposal of interest in Mitre Passage
12th Feb 20147:00 amRNSInterim Management Statement
7th Feb 20147:00 amRNSQuintain acquires Kingsbourne House
4th Feb 20144:31 pmRNSTotal Voting Rights
4th Feb 20144:28 pmRNSDirector/PDMR Shareholding
30th Jan 20144:30 pmRNSDirector/PDMR Shareholding
7th Jan 20144:32 pmRNSBlocklisting Interim Review
7th Jan 20144:31 pmRNSBlocklisting Interim Review
7th Jan 20144:30 pmRNSDirector/PDMR Shareholding
7th Jan 20144:30 pmRNSDirector/PDMR Shareholding
7th Jan 20144:30 pmRNSTotal Voting Rights
27th Dec 20139:43 amRNSHolding(s) in Company
10th Dec 20139:30 amRNSDirector/PDMR Shareholding
5th Dec 20131:05 pmRNSHolding(s) in Company
3rd Dec 20139:30 amRNSHolding(s) in Company
3rd Dec 20139:06 amRNSTotal Voting Rights
3rd Dec 20139:05 amRNSDirector/PDMR Shareholding
25th Nov 20137:00 amRNSResults for the six months ended 30 September 2013
21st Nov 20131:15 pmRNSGeneral Meeting voting results
8th Nov 20134:00 pmRNSNotice of Interim Results
7th Nov 20134:30 pmRNSDirector/PDMR Shareholding
7th Nov 201311:00 amRNSHolding(s) in Company
6th Nov 20139:00 amRNSChange in Director's details

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.